اهتمام السوق بمستقبلات الأوركسين

ALKS stock volatility (30-day implied volatility) will increase by at least 25% within 60 days as market participants price in orexin receptor commercial opportunity potential

Orexin receptor market expansion will result in ALKS achieving a market capitalization increase of at least 20% within 120 days, driven by investor sentiment and pipeline expansion expectations

Increasing orexin receptor agonist market interest will drive ALKS stock price to outperform the broader biotech sector (XBI) by at least 15% within 90 days